摘要
目的分析舒利迭与孟鲁司特钠联合治疗支气管哮喘的临床效果。方法将125例支气管哮喘患者分为2组,实验组63例给予舒利迭与孟鲁司特钠联合治疗,对照组62例给予单纯孟鲁司特钠治疗。结果研究组总有效率(96.83%)高于对照组(70.97%),其治疗后FEV1[(90.13±15.84)%]、FVC[(95.23±12.67)%]、PEF[(81.10±8.74)%]高于对照组[FEV1:(80.11±13.61)%、FVC:(81.16±15.97)%、PEF:(64.49±9.37)%],两组差异有统计学意义(P<0.05)。结论舒利迭与孟鲁司特钠联合治疗支气管哮喘,临床疗效显著,FEV1、FVC、PEF改善明显。
Objective To analyze the clinical effects of seretide and montelukast sodium combined with treatment of bronchial asthma. Methods125 cases of bronchial asthma were divided into 2 groups, 63 cases in experimental group were given seretide and montelukast sodium combined therapy, 62 cases in the control group treated with montelukast sodium in the treatment of.ResultsThe study group total effective rate （96.83%） was signiifcantly higher than the control group （70.97%）, after the treatment of early FEV1[（90.13± 15.84）, FVC[（95.23± 12.67） of early, PEF[（81.10± 8.74） of early than that in the control group [FEV1： （80.11 ± 13.61）%, FVC： （81.16± 15.97）%, PEF： （64.49± 9.37） of early, with a signiifcant difference between two groups （P〈0.05）.Conclusion Seretide and montelukast sodium combined with treatment of bronchial asthma, clinical curative effect, FEV1, FVC, PEF improved signiifcantly.
出处
《中国继续医学教育》
2015年第12期117-118,共2页
China Continuing Medical Education
